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Abstract
Background
The impact of maternal ingestion of peanut during pregnancy and lactation on an offspring’s
risk for peanut allergy is under debate.
Objective
To investigate the influence of maternal dietary peanut exposure and breast milk on an off-
spring’s allergy risk.
Methods
Preconceptionally peanut-exposed C3H/HeJ females were either fed or not fed peanut dur-
ing pregnancy and lactation. The offsprings’ responses to peanut sensitization or oral toler-
ance induction by feeding antigen prior to immunization were assessed. We also assessed
the impact of immune murine milk on tolerance induction pre- or post-weaning. For antigen
uptake studies, mice were gavaged with fluorescent peanut in the presence or absence of
immune murine milk; Peyer’s patches were harvested for immunostaining.
Results
Preconceptional peanut exposure resulted in the production of varying levels of maternal
antibodies in serum (and breast milk), which were transferred to the offspring. Despite this,
maternal peanut exposure either preconceptionally or during pregnancy and lactation,
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when compared to no maternal exposure, had no impact on peanut allergy. When offspring
were fed peanut directly, dose-dependent tolerance induction, unaltered by maternal feed-
ing of peanut, was seen. Although peanut uptake into the gut-associated lymphoid tissues
was enhanced by immune milk as compared to naïve milk, tolerance induction was not
affected by the co-administration of immune milk either pre- or post-weaning.
Conclusion
Maternal peanut exposure during pregnancy and lactation has no impact on the develop-
ment of peanut allergy in the offspring. Tolerance to peanut can be induced early, even pre-
weaning, by giving moderate amounts of peanut directly to the infant, and this is neither
enhanced nor impaired by concurrent exposure to immune milk.
Introduction
Peanut allergy is an example of a defect in the development of oral tolerance, which refers to
the normal suppression of systemic immune responses to antigens first encountered by the
oral route. The prevalence of peanut allergy has dramatically increased in children within the
last decade, affecting over 1% of school-aged children in the United States, United Kingdom,
Canada, and Australia. [1–4] The majority of initial reactions to peanut and tree nuts occur on
the first known ingestion [5], suggesting that sensitization likely occurred through another
route, such as inhalation, epicutaneous, in utero, or through breast milk. Because maternal,
rather than paternal, atopic status has a greater effect on the atopic outcome of the progeny [6],
perinatal factors including maternal diet and immune status may play a critical role in the
development of peanut allergy. Although dietary antigens, such as peanut, egg, and cow’s milk
proteins, have been detected in breast milk [7–10] in concentrations sufficient to cause symp-
toms in individuals already sensitized [10], observational studies provide mixed evidence about
the potential role of exposure to peanut through breast milk in the initial sensitization phase.
[11–12] All the studies possess potential recall bias and no prospective controlled human clini-
cal trials are available. Furthermore, infant diet, which is typically linked to the maternal diet,
may be a confounding factor. In fact, the recent randomized LEAP trial of oral peanut exposure
in infancy showed early exposure to be highly efficacious in prevention of peanut allergy in
high-risk individuals. [13] However, the role of maternal diet including or excluding peanut in
the development of peanut allergy remains unclear.
A murine model of peanut allergy can be a useful tool for initial investigation of interven-
tions for peanut allergy. [14] The advantage of using an animal study is the ability to strictly
control dietary and environmental exposure. Previous animal studies on maternal exposure
showed a protective effect of ovalbumin (OVA) transfer through murine milk in offspring [15–
18], which was reportedly dependent on TGF-ß in milk and induction of T regulatory cells in
one study [15] or vertical transfer of IgG-OVA complexes in another study. [17] We have pre-
viously shown that ante- and perinatal feeding of low dose peanut to mothers prevented sensi-
tization and anaphylactic reactions in their offspring during the first peanut exposure. [14]
Protection was associated with increased peanut-specific IgG2a, which was related to the co-
administration of peanut with a mucosal adjuvant during pregnancy and lactation. While the
use of an adjuvant may be useful for therapeutic purposes, our goal was to address the impact
of a normal maternal dietary exposure on the risk of allergy in the offspring.
Maternal Diet in Food Allergy
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Prevention of food allergies by infant feeding practices serves as a simple, inexpensive
approach to address the growing incidence of food allergy. We sought to assess the impact of
maternal perinatal ingestion of peanut and other food allergens (without sensitization of moth-
ers or co-administration with a mucosal adjuvant) on an offspring’s risk of developing an
allergy or ability to develop tolerance to food. In addition, the isolated impact of breast milk on
tolerance induction was assessed. Because the production of food-specific IgG antibodies is a
normal physiologic phenomenon following ingestion of foods and because maternal IgG anti-
bodies have been associated with protection against sensitization in offspring [17], we used
mothers with previous exposure and presence of antibodies as biomarkers of exposure. We
show that, in mice, maternal perinatal ingestion of peanut has little impact on the development
of tolerance or allergy to peanut in their offspring and that the early introduction of peanut
directly to the infant, in the presence or absence of breast milk, induces oral tolerance.
Methods
Animals, antigens and adjuvants
Six-week-old female and male C3H/HeJ mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). BALB/c female mice (5–8 weeks old) were obtained from Taconic Farms
(Hudson, NY). Animals were maintained on peanut-free chow under conventional, specific
pathogen-free conditions. At the end of the experiments, animals were sacrificed by cervical
dislocation. Freshly ground whole roasted peanut for maternal feeding and oral challenges was
prepared as previously described. [19] Defatted crude peanut extract (CPE) was used as an
antigen in sensitization and tolerance protocols, intraperitoneal (i.p.) challenges and laboratory
assays. CPE labeled with fluorescein (FITC) was used for uptake studies. [14] OVA and beta-
lactoglobulin (BLG) were purchased from Sigma. Cholera toxin (CT) was purchased from List
Biological Laboratories Inc (Campbell, CA).
Ethics statement
Albany Medical College Institutional Animal Care and Use Committee (IACUC) approved the
study (protocol #11–10003).
Maternal exposure
In order to determine the influence of maternal peanut ingestion during pregnancy and lacta-
tion on the development of peanut allergy in offspring, female C3H/HeJ mice were gavage-fed
with ground peanut (10 mg/mouse) three times a week for four weeks prior to conception.
Saphenous venous blood was collected at week 5 to determine CPE-specific IgG1, IgG2a, and
IgA levels. Subsequently, they were mated with naïve males. These preconceptionally (PC) pea-
nut-exposed mothers were divided into 2 groups for the period of pregnancy (PG) and lacta-
tion (LC): those who were gavage-fed peanut (10 mg) three times a week (PC+PG+LC) and
those who were on the normal mouse chow alone, which does not contain peanut (PC). Addi-
tional peanut was left in the cages to be ingested ad libitum by mothers as indicated by their
group assignment. Naïve mothers not fed peanut during pregnancy and lactation were used as
controls (None). These mothers were then used as breeders for mice utilized in the following
experiments of sensitization or tolerance induction as described below; alternatively only their
milk was used, as shown in Fig 1. (Please see S1A Fig for a detailed protocol on maternal feed-
ing.) These mothers develop IgG, but not IgE antibodies to peanut, and are not clinically reac-
tive to peanut. Offspring of these mothers were weaned between 3.5 and 4 weeks of age.
Maternal Diet in Food Allergy
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Additional groups included preconceptionally peanut exposed mothers who were fed peanut
only during pregnancy and those who were fed peanut only during lactation (not shown).
Sensitization, allergen challenge and assessment of anaphylaxis
Five-week old C3H/HeJ offspring were sensitized with CPE+CT by gavage (5 mg CPE + 20 μg
CT/mouse) at weekly intervals for 6 weeks followed by 2 boosters at 2-week intervals (50 mg
CPE + 20 μg CT/mouse), as previously published [20]. (Please see S1B Fig for a detailed proto-
col on offspring sensitization.) Offspring were bled prior to sensitization at week 5 and post-
sensitization at week 15 of life, and peanut-specific IgE, IgG1, IgG2a, and IgA were measured
by ELISA, as described below. Two weeks after the last booster, an oral challenge with 100 mg
peanut i.g. was performed, followed by an intraperitoneal injection of 100 μg CPE after 30 min-
utes. Anaphylactic signs were evaluated 30 minutes after the challenge dose, according to a pre-
viously published scoring system. [19] Rectal temperatures were measured 30 minutes after the
peanut challenge with a thermal probe (WPI Instrument, Sarasota, FL). Mast cell protease-1
(MMCP) was measured within 1 hour post-challenge utilizing an ELISA kit (R&D Systems).
Splenocytes were harvested for cultures as described below.
Tolerance induction
To determine the influence of maternal peanut ingestion on the development of oral tolerance
in offspring, we performed a classic oral tolerance protocol on offspring. Offspring were
weaned between 3.5 and 4 weeks of age, bled, and immediately gavage-fed 1 mg CPE daily for 5
days, followed by two immunizations with 0.1 mg CPE with alum i.p. after 2 weeks at weekly
intervals. (Please see S1C Fig for a detailed protocol on tolerance induction.) Offspring that
were not fed CPE (fed bicarbonate alone) prior to immunization served as controls. Peanut-
specific IgE, IgG1, IgG2a, and IgA were measured by ELISA, as described below. This model is
not sufficiently sensitized to assess symptomatic anaphylaxis.
Fig 1. Experimental protocols.Grey shaded boxes indicate periods of oral peanut exposure. Mothers were exposed to ground peanut for 4 weeks during
either in the pre-conception period only (PC), during preconception, pregnancy and lactation (PC+PG+LC); or were not fed peanut, serving as controls
(None). All the offspring underwent oral sensitization to peanut by being gavage-fed crude peanut extract (CPE) with cholera toxin or were tolerized by being
gavage-fed CPE without adjuvant. In some experiments, young mice born to naïve mothers were exposed to the milk of naïve (naïve milk) or peanut-exposed
(immune milk) mice concurrently with CPE and cholera toxin to induce peanut sensitization or CPE alone to induce oral tolerance.
doi:10.1371/journal.pone.0143855.g001
Maternal Diet in Food Allergy
PLOS ONE | DOI:10.1371/journal.pone.0143855 December 10, 2015 4 / 17
Impact of breast milk on tolerance induction
The role of breast milk on tolerance induction was assessed in 11-12-day-old and 3–4 week-old
mice (born to naïve mothers) that were subjected to a classic oral tolerance protocol. (Please
see S1D Fig for a detailed protocol on the impact of breast milk.)
These offspring were fed 1 mg CPE i.g. daily for 5 days, followed by 2 immunizations with
CPE in alum after 2 weeks at weekly intervals. Alternatively, CPE was administered in the pres-
ence of naïve or immune milk (i.e. milk from peanut-exposed animals). Offspring that were
not fed CPE (fed bicarbonate alone) prior to immunization served as controls. Offspring were
bled a week after the last immunization.
In addition, the impact of breast milk on sensitization was assessed in 3–4 week-old mice
that were exposed to OVA in the presence or absence of immune or naïve milk, followed by
OVA epicutaneous sensitization [21] and challenge as described in Supplemental Methods.
Cell culture and cytokine measurements
Splenocytes derived from sensitized offspring were isolated using standard techniques. After
the red blood cells were lysed, splenocytes were resuspended in RPMI 1640, supplemented
with fetal bovine serum. Cells were cultured in 24-well plates (4×106/well/mL) in the presence
or absence of CPE (200 μg/mL). Supernatants were collected after 72 hours and IL-5, IL-10, IL-
13, and IFN-γ levels were determined by ELISA, according to the manufacturer’s instructions
(EBioscience Affymetrix Inc, San Diego, CA).
Measurement of antibodies
Breast milk was collected using an electric murine breast pump and processed. [22] Serum and
milk samples were stored at -80°C until analyzed. CPE-specific IgE in serum was measured by
a capture enzyme-linked immunosorbent assay. [23] CPE-specific IgG1, IgG2a, and IgA were
measured by applying serum and breast milk dilutions to CPE-coated plates and detected with
biotinylated anti-IgG1, IgG2a, and IgA, respectively, and total IgE was measured using an
ELISA kit (BD Pharmingen, San Diego, CA).
In vivo antigen uptake studies
BALB/c mice have been used in our laboratories in the past to assess antigen uptake. They were
gavaged with 0.5 mg/ml of FITC-labeled CPE in 0.1M sodium bicarbonate. FITC-CPE was
pre-mixed with mouse milk obtained from antigen-exposed (immune, PC+PG+LC group) or
non-exposed (naïve) mice. After ten minutes, gavage mice were sacrificed and Peyer’s patches
(PP) were harvested. PP tissues were processed for immunofluorescence as previously
described. [24]
Immunofluorescence
PP sections were stained as previously described. [24] The anti-mouse antibody CD11c-PE
from eBioscience (San Jose, CA) was used for immunostaining dendritic cells in PP tissues. All
incubations were done at 37°C for 30 min. Slides were mounted with ProLong Gold antifade
reagent (Invitrogen, Grand Island, NY) and images were collected using a Leica SP5 ABOS
scanning laser confocal microscope (Leica, Wetzlar, Germany). Images were processed using
the Fiji software (http://fiji.sc/). [25]
Maternal Diet in Food Allergy
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Statistical analysis
We performed a one-way ANOVA followed by a Newman Keuls test for all pairwise compari-
sons if the data were normally distributed. For antibody dilution curves, data were analyzed by
a two-way ANOVA with a Bonferroni correction for multiple comparisons. Differences
between groups were analyzed by a nonparametric test followed by all pairwise comparisons if
the data was not normally distributed, with a Dunn’s test for multiple comparisons. Pre-post
values were analyzed by Wilcoxon signed rank test. P values<0.05, based on two-tailed tests,
are considered statistical significant. All statistical analyses were performed with Prism 5.0
(GraphPad, Inc.).
Results
Maternal peanut exposure prior to conception results in antibody
production in serum and breast milk and transfer of immunoglobulins to
offspring
To assess the efficacy of antibody production induced by oral exposure to peanut, we measured
the antibody levels in maternal serum and breast milk. Three weeks after oral gavage with pea-
nut, more than one-half of the mothers exposed to peanut prior to conception, had detectable
levels of CPE-specific serum and breast milk IgG1 and IgG2a, whereas mice that were not
exposed to peanut did not (Fig 2A–2D). Specific IgE was undetectable and these mothers were
not reactive to peanut upon feeding. Also, feeding peanut throughout lactation did not further
boost antibody levels (data not shown).
Maternal CPE-specific serum antibody levels were efficiently transferred to the offspring, as
evidenced by elevated specific IgG1 and IgG2a levels in pups born to peanut-exposed mothers
(Fig 2E and 2F). Pups born to non-exposed mothers had no detectable CPE-specific antibody
at weaning. Maternal antibody levels positively correlated with IgG1 and IgG2a antibody levels
in offspring at weaning (p<0.001 and p = 0.002, respectively, S2 Fig). Feeding peanut through-
out lactation did not further boost antibody levels in offspring (data not shown).
Maternal peanut exposure during pregnancy and lactation had no impact
on peanut sensitization
We then assessed whether maternal feeding of peanut during pregnancy and lactation had an
impact on development of peanut sensitization in the offspring. Peanut sensitization was asso-
ciated with increased serum peanut-specific IgE, IgG1, IgG2a, and IgA levels, which were com-
parable among the 3 groups of offspring: those born to non-exposed mothers versus those
born to mothers exposed to peanut prior to conception or those exposed prior to conception
and throughout pregnancy and lactation (Fig 3B–3E). After the oral peanut challenge, the
symptom scores were comparable among these 3 groups (Fig 3F), and similar drops in body
temperature were observed after i.p. peanut challenge (Fig 3G). MMCP-1 and cytokine levels
from splenocyte cultures were likewise comparable between the 3 groups (See S3 Fig). Serum
levels of total IgE, specific IgE to Ara h2, and ratios of specific IgE and IgG1 to IgG2a were
comparable between the three groups of mice (data not shown). Additional groups of offspring
born to mothers exposed to peanut prior to conception, and either exposed to peanut only dur-
ing pregnancy or only during lactation, had comparable levels of antibodies and challenge
responses (data not shown). Experiments were repeated using the milk allergen BLG as an anti-
gen. There were again no significant differences among the groups (S4 Fig).
Maternal Diet in Food Allergy
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Fig 2. Mothers’ preconception serum (A-B) and breast milk (C-D) antibody levels in mothers who were fed peanut preconceptionally (PC) and in
those who were not (None). Presensitization antibody levels at 5 weeks of age are shown (E-F) for offspring born to peanut-exposed mothers who either
continued to feed peanut throughout pregnancy and lactation (PG+LC) and in those who did not (PC). The dilution curves are not shown due to the small
amount of serum available. Specific IgE was undetectable (data not shown). Titles indicate sample dilution. Shown is a mean (with SEM). 5–10 mothers per
group and all their offspring (>15/group) were used for each experiment. *, p<0.05; **, p<0.01; ***, p<0.001 compared to None.
doi:10.1371/journal.pone.0143855.g002
Maternal Diet in Food Allergy
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Oral tolerance to peanut develops independently of maternal peanut
exposure
Food allergy is thought to be a combined result of failed oral tolerance and an activation of
pathways that promote sensitization. We then assessed whether maternal feeding of peanut
would impact offsprings’ development of oral tolerance. This was done utilizing a classic oral
tolerance protocol, in which daily antigen feeding for 5 days induces a suppressed antibody
response to immunization with the same antigen. We found that tolerance was induced in
young mice by feeding a moderate dose (1 mg) of CPE prior to immunization, as evidenced by
lower levels of specific IgE antibodies (Fig 4), IgG1, and IgG2a antibodies were also decreased,
but not statistically different between the groups (Please see S5 Fig). We also showed that toler-
ance development was as effective in mice born to mothers exposed to peanut prior to concep-
tion and throughout pregnancy as mice born to non-peanut-exposed mothers (Fig 4).
Fig 3. Offspring’s response to peanut sensitization based onmaternal feeding of peanut. (A) Experimental protocol. Serum antibodies (B-E) and an
anaphylactic response to the peanut challenge as indicated by the elevated score during the oral (PO) challenge (F) (baseline symptom score 0 in all the
mice), the lowered body temperature during the intraperitoneal (IP) challenge (G), and after the peanut sensitization were assessed in offspring born to
mothers exposed to peanut preconceptionally, who either continued to feed peanut during pregnancy and lactation (PC+PG+LC) and those who did not
(PC). Offspring born to mothers never exposed to peanut served as controls (None). Naïve, non-sensitized mice served as controls. Shown is a mean with
SEM. >15 mice were used per group.
doi:10.1371/journal.pone.0143855.g003
Maternal Diet in Food Allergy
PLOS ONE | DOI:10.1371/journal.pone.0143855 December 10, 2015 8 / 17
Peanut uptake into Peyer’s patch associated dendritic cells
It has been reported that breast milk OVA-IgG immune complexes facilitate oral tolerance in
neonates due to enhanced uptake across the mucosal barrier through the neonatal Fc receptor.
[17] To examine the role of antibodies in uptake of peanut antigens following oral delivery,
FITC-CPE was administered orally to 5 week-old mice in the presence of immune or naïve milk.
We excised small intestinal tissues containing at least one Peyer’s patch and subjected the tissues
to cryosectioning and confocal microscopy. In the context of naïve milk, we observed the accu-
mulation of FITC-CPE within a subset of Peyer’s patch subepithelial dome dendritic cells (DCs),
as evidenced by co-localization of CPE with CD11c+ cells (Fig 5). CPE was not visibly detected in
the lamina propria. Co-administration of FITC-CPE with immune milk slightly enhanced
FITC-CPE uptake in Peyer’s patch tissues when compared to administration of CPE with naïve
milk, thus suggesting that the presence of antigen-specific IgG or IgA antibodies may facilitate
transport of CPE across the follicle-associated epithelium and/or uptake by DCs.
Oral tolerance can be induced in early life, and is neither enhanced nor
impaired by concurrent exposure to immune breast milk
Lastly, because we detected enhanced peanut uptake in Peyer’s patches in the presence of pea-
nut antibodies in breast milk, we hypothesized that direct administration of antigen to the
Fig 4. Maternal feeding of peanut does not interfere with the induction of oral tolerance in offspring. (A) Experimental protocol. (B-D) Serum IgE
antibodies after peanut immunization were assessed in offspring who were either fed crude peanut extract (CPE) orally prior to immunization with CPE (Fed)
or not fed (Unfed). Offspring were either born to mothers exposed to peanut preconceptionally who either continued to feed peanut during pregnancy and
lactation (PC+PG+LC) or did not (PC). Offspring born to mothers that were never exposed to peanut served as controls (None). In (C), although antibody
levels are similar, the dilution curves are significantly different. Shown is a mean with SEM. Each group has 10–18 mice *, p<0.05, ****, p<0.0001.
doi:10.1371/journal.pone.0143855.g004
Maternal Diet in Food Allergy
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offspring to induce oral tolerance could be influenced by concurrent immune milk exposure.
We fed offspring CPE plus murine milk, either at weaning (Fig 6A–6D) or prior to weaning, at
11 days of age (Fig 6E–6H). We showed that a relatively small dose of fed CPE (1 mg) adminis-
tered alone, post-weaning, was able to tolerize offspring, but co-administration with immune
or naïve murine milk did not have any impact on this tolerance development (Fig 6A and 6B).
Because the mice above were tolerized post-weaning, we then assessed whether the pre-wean-
ing period would be more susceptible for tolerance induction by immune milk. This was done
by utilizing mice at 11–12 days of life and treating them with two doses of antigen. Again, we
showed that that immune milk did not significantly impact tolerance induction (Fig 6E–6H).
We also showed that a large dose of CPE was better at inducing tolerance than small or trace
quantities of antigen (Fig 6E–6H).
We also assessed the impact of fed OVA co-administered with murine milk followed by
OVA sensitization, with similar results (Fig 7).
Discussion
The prevalence of peanut allergy has increased in children. [1–4] Peanut is commonly known
as a cause for fatal and near-fatal anaphylactic reactions [26–27] and rarely outgrown. Because
prevention of food allergies by maternal and infant feeding practices could serve as a simple,
inexpensive approach to address the growing number of subjects with food allergies, we
assessed whether maternal peanut exposure has an impact on peanut sensitization in the off-
spring. We report that despite vertical transfer of maternal antibodies, maternal peanut expo-
sure and immune status had no significant impact on development of sensitization or
tolerance in the offspring. In addition, we show that early introduction of peanut directly to the
offspring induces dose-dependent tolerance, which is not further facilitated by co-administra-
tion of immune breast milk. These findings suggest that (i) the maternal diet plays little role in
the development of peanut allergy and (ii) tolerance can be induced early, even pre-weaning,
by introducing moderate amounts of peanut directly to the infant, with or without concurrent
exposure to immune breast milk. Our study does not address the question of whether breast-
feeding overall has an impact on sensitization or tolerance, because all the offspring were
breastfed.
Fig 5. Intestinal peanut uptake to the Peyer’s patches.Mice were gavage-fed FITC-labeled CPE in the presence of naïve murine milk or immune milk.
Peyer’s patches were collected 10 min later. A-B show representative sections of immunofluorescence. FAE, follicle associated epithelium; SED,
subepithelial dome. FITC, CPE; Magenta, CD11c+. C) Number of DCs staining positive for CPE per patch. **, p<0.01 when compared to immune milk.
doi:10.1371/journal.pone.0143855.g005
Maternal Diet in Food Allergy
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Our results differ from several previous animal studies that have shown protection with
maternal exposure against sensitization to inhaled or ingested antigens. They have mostly been
performed using OVA as an antigen in asthma models [15–18], as opposed to an oral peanut
allergy model. Peanut, as opposed to OVA, activates innate immunity and complement [28–
29], which may be related to greater clinically evident allergenicity. However, our studies with
two other common food allergens, cow’s milk β-lactoglobulin and hen’s egg OVA, support our
findings. Only one study to date has assessed maternal peanut exposure and using mothers sen-
sitized to peanut showed protection provided by low dose, perinatal maternal peanut exposure
against peanut anaphylaxis during first exposure. Protection was associated with increased pea-
nut-specific IgG2a in the offspring, [14] related to co-administration of peanut with a mucosal
adjuvant. In the current study, peanut was fed to mothers perinatally without a mucosal adju-
vant, which is more relevant to the human population in which peanut ingestion typically
occurs as part of a diet without co-administration of an adjuvant. Also, mothers who were
allergic to peanut would not be ingesting peanut. Consistently, no enhanced IgG2a responses
were detected in the current study, indicating that adjuvant use may explain the different
Fig 6. Dose-dependent induction of oral tolerance to peanut in mice prior to or after weaning.Mice post-weaning at 3–4 weeks of age (n = 5/group)
(A-D), or pre-weaning at 11–12 days of age (n = 7-9/group (E-H) were fed crude peanut extract (CPE, 1 mg or as otherwise indicated) +/- murine milk
(immune, unless otherwise indicated being naive) for 5 days followed by immunization with CPE. Mice immunized without prior feeding of ground peanut
(Unfed) were used as untolerized controls. Shown is a mean with SEM. **, p<0.01, ***, p<0.001, ****, p<0.00001 when compared to unfed.
doi:10.1371/journal.pone.0143855.g006
Maternal Diet in Food Allergy
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outcomes between the studies. Different outcome may also be due to the fact that whereas the
current model was IgE-mediated, anaphylaxis during first exposure in the previous model was
IgG1-mediated. Also, because patients with peanut allergy strictly avoid the allergen, our study
determined that the impact of maternal ingestion of peanut in mothers with previous exposure
and presence of specific antibodies to peanut are associated with maternal tolerance, not
sensitization.
In humans, there is likewise great controversy regarding the impact of maternal avoidance
diets on allergy prevention. [30–33] Unlike the previous recommendations, [34] the revised
maternal and infant feeding guidelines avoid strong recommendations on whether foods of high
allergenic potential should be ingested during lactation. [35] More recently, emerging observa-
tional studies have created even more controversy. [11–13] Recently, two large US cohorts per-
formed in general populations [12–13] reported that a maternal diet including peanut and tree
nuts during or around pregnancy could be associated with a reduced risk to peanut or tree nut
Fig 7. OVA epicutaneous sensitization after feeding OVA with or without murine milk. (A) Experimental protocol. Offspring come from naïve mothers.
Offspring’s response to OVA challenge (B-C) and antibody responses to OVA sensitization (D-F). Mice post-weaning at 3–4 weeks of age were fed OVA +/-
OVA-immune or naïve milk for 5 days followed by cutaneous sensitization with OVA. Mice immunized without prior OVA feeding (Unfed) were used as
controls. X axis for D-F shows the dilution factor for the serum. Each group has 5 mice. Shown is a mean with SEM. **, p<0.01, ***, p<0.001, ****,
p<0.00001 when compared to unfed.
doi:10.1371/journal.pone.0143855.g007
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allergy in offspring. However, when nut allergic mothers were assessed separately, one study
reported a trend for an association between maternal consumption of tolerated nuts and
increased risk of peanut or tree nut allergy in offspring. [13] This is consistent with findings in a
human cohort of high-risk infants with possible or likely cow’s milk or egg allergy that reported
maternal peanut ingestion during pregnancy associated with increased peanut sensitization. [11]
Because controlled clinical trials are lacking, confounding factors such as the infant’s diet and
other environmental exposures may partly explain the differences in findings between cohorts.
The capacity of food antigens in breast milk to sensitize or tolerize is largely unknown. Pea-
nut proteins [7–8] and several other dietary proteins, including cow’s milk, hen’s egg and
wheat allergens, have been detected in human and murine milk. [7, 8, 15] We anticipated that
peanut would also be transmitted in murine milk, although in small quantities. These levels did
not seem to play a major role in sensitization or tolerance induction. Due to the fact that levels
of dietary antigens present in breast milk are generally very low with many mothers having
undetectable levels, [7, 8, 10] we also assessed the potential of larger doses of peanut co-admin-
istered with immune milk in inducing tolerance. We showed that large doses of peanut were
better at inducing tolerance to peanut in young mice than small doses or trace amounts and
that tolerance induction was not impacted by co-administration with immune milk. This sug-
gests that low levels of dietary antigens present in breast milk may not be sufficient to induce
tolerance and that doses larger than trace amounts are required. This was surprising in light of
the finding that milk antibodies enhanced peanut uptake in Peyer’s patches. While animal
studies are not a surrogate for human trials, our results suggest that the impact of maternal die-
tary antigens may be small compared to other factors, including epicutaneous exposure, which
has been associated with sensitization [21, 36–38] and early oral exposure, as recently shown in
the LEAP study to lead to tolerance induction. [13] Our findings further support the early
introduction of foods directly to infants for development of tolerance,and although the exact
“window of opportunity” cannot be extrapolated from mouse studies, introduction may be
beneficial even pre-weaning without a risk of sensitization.
Our finding that breast milk does not appear to facilitate tolerance development in offspring
pre- or post-weaning is in disagreement with a recent study, which showed that low quantities
of immunologically active peanut allergens were secreted in human breast milk and co-admin-
istration of peanut with breast milk was associated with partial tolerance to peanut when
administered to young mice prior to weaning. [8] The authors suggested that protection may
be transferred via human milk antibodies and a neonatal γ receptor (FcRn), which may bind
antibodies from different species. The main difference, compared to our study, was that we
administered breast milk from the same species, namely murine milk, to assure that receptors
facilitating antibody uptake in the neonatal gut would be appropriate to the species used.
During maternal exposure, handling pregnant mothers and gavaging these mice consis-
tently can induce stress related changes in immune responses in the pups. A limitation to this
study is that the control group was not gavaged a vehicle as compared to the pregnant mothers
who were gavage fed peanut three times a week. However, mothers in each group were handled
frequently and additionally stressed on a weekly or twice-a-week basis, due to milking and
blood draws. Furthermore, because sensitization may be dependent on presensitization IgG
levels, and offsprings’ presensitization IgG levels were highly variable, the conclusions might
have been different if only offspring with high IgG1 levels would have been taken into account.
Due to initial study design not accounting for this, the experiments were not sufficiently pow-
ered to perform such analyses.
In summary, despite vertical transfer of maternal IgG antibodies, we found that ante- and
postnatal maternal peanut exposure does not impact peanut sensitization or oral tolerance
induction in offspring, which suggests that no dietary restrictions are needed for pregnant and
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breastfeeding mothers in order to prevent food allergy. However, there is emerging evidence to
suggest that early peanut introduction directly to infants is beneficial in prevention of peanut
allergy, providing rationale for current interim feeding guidelines. [39] Furthermore, large
doses of peanut were better at inducing tolerance to peanut than small doses and tolerance
induction was not impacted by co-administration of immune milk either pre- or post-weaning,
suggesting that trace amounts of dietary protein detected in breast milk may not be sufficient
to induce significant tolerance. Randomized controlled clinical studies are needed to address
the impact of maternal exposure to peanut and the “window of opportunity” for early intro-
duction of foods on allergy risk in humans.
Supporting Information
S1 Fig. Detailed experimental protocol. (A) To assess the impact of the maternal diet, moth-
ers were pre-conceptionally exposed to crude peanut extract (CPE) (Immune Mothers). During
pregnancy and lactation, they were divided into those who continued to feed CPE (PG+LC)
and those who did not (None). Non-CPE-exposed mothers that did not feed CPE pre- or post-
conception served as controls. After weaning, offsprings’ responses to peanut sensitization (B)
or oral tolerance induction (C) were assessed. (D) To assess the role of murine milk, oral toler-
ance induction or sensitization to CPE was assessed in young mice pre- or postweaning by
feeding CPE alone or with murine milk from immunized mothers.
(PDF)
S2 Fig. Offsprings’ presensitization antibodies. Antibodies were assessed after weaning and
before immunization in offspring born to immune mothers who fed peanut during pregnancy
and in those who did not (A-B). Offspring antibodies are plotted according to maternal anti-
bodies, being either high or low. Specific IgE or IgA were undetectable. , p<0.05, ,p<0.01,
, p<0.001.
(PDF)
S3 Fig. Offspring’s response to peanut sensitization based on maternal feeding of peanut.
(A) SerumMMCP levels were measured 30 min after intraperitoneal peanut challenge. (B-D)
Cytokine levels were measured in splenocyte cultures stimulated with peanut for 72 hours. In
offspring born to mothers exposed to peanut preconceptionally, who either continued to feed
peanut during pregnancy and lactation (PC+PG+LC) and in those who did not (PC). Offspring
born to mothers never exposed to peanut served as controls (None). Naïve, non-sensitized
mice served as controls. Shown is a mean with SEM.
(PDF)
S4 Fig. Offspring’s response to BLG sensitization based on maternal feeding of BLG. Exper-
imental protocol (A). Mothers’ preconception serum (B) and breast milk (C) antibody levels in
mothers who were fed BLG preconceptionally (BLG Fed) and in those who were not (Naive).
Offspring were sensitized to BLG and serum antibodies (D-F) and symptom scores were mea-
sured after oral (PO) feeding (G) and body temperature measured after intraperitoneal (IP)
injection of BLG (H), in offspring born to mothers exposed to BLG only preconceptually (PC)
and in those who continued to feed BLG during pregnancy and lactation (PC+PG+LC). Off-
spring born to mothers never exposed to BLG served as controls (None). Shown is a mean with
SEM. Each group has 4–12 mice. , p<0.01.
(PDF)
S5 Fig. Maternal feeding of peanut does not interfere with the induction of oral tolerance
in offspring. (A-C) Serum CPE-specific IgG1 and (D-F) IgG2a antibodies after PN
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immunization were assessed in offspring who were either fed PN orally prior to immunization
(Fed) or not fed (Unfed). Offspring were either born to mothers exposed to CPE preconcep-
tionally who either continued to feed peanut during pregnancy and lactation (PC+PG+LC)
and in those who did not (PC). Offspring born to mothers never exposed to peanut served as
controls (None). Shown is a mean with SEM. Each group has 10–18 mice. , p<0.01, ,
p<0.001.
(PDF)
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